Outcome of Diffuse Large B-Cell Lymphoma in the United States Has Improved Over Time but Racial Disparities Remain: Review of SEER Data-Reference-Cited by-同舟云学术

Outcome of Diffuse Large B-Cell Lymphoma in the United States Has Improved Over Time but Racial Disparities Remain: Review of SEER Data

Published:2011-06 Issue:3 Volume:11 Page:257-260
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Komrokji Rami S.,Al Ali Najla H.,Beg M.S.,Safa Malek M.,Rollison Dana,Kharfan-Dabaja Mohamed,Bello Celeste,Cultrera Jennifer,Sokol Lubomir,Pinilla-Ibarz Javier,Sotomayor Eduardo M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference7 articles.

1. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001;Morton;Blood,2006

2. WHO Classification of Tumours of Haematopoietic andLymphoid Tissues,2008

3. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

4. 10 years follow-up of the GELA LNH98.5 study: first randomized study comparing R-CHOP to CHOP chemotherapy in patients with diffuse large B-cell lymphoma;Coiffier;Blood,2009

5. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma;Habermann;J Clin Oncol,2006

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of race/ethnicity and insurance with survival in patients with diffuse large B‐cell lymphoma in a large real‐world cohort;Cancer Medicine;2024-08

2. Disparity in hematological malignancies: From patients to health care professionals;Blood Reviews;2024-05

3. Bridging the gap: how do we enroll more racial-ethnic minority patients in hematological drug trials?;Expert Review of Hematology;2023-10-27

4. Representation of the population in need for pivotal clinical trials in lymphomas;Blood;2023-08-31

5. Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-05